NMDA receptor signaling induces the chemoresistance of temozolomide via upregulation of MGMT expression in glioblastoma cells

[1] Miller KD(2021)Brain and other central nervous system tumor statistics, 2021 Cancer J Clin 71 381-406

[2] Ostrom QT(2019)CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016 Neuro Oncol 21 v1-v100

[3] Kruchko C(2021)The 2021 WHO classification of tumors of the central nervous system: a summary Neuro Oncol 23 1231-1251

[4] Patil N(2005)Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987-996

[5] Tihan T(2005)MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 997-1003

[6] Cioffi G(1995)Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase Prog Nucleic Acid Res Mol Biol 51 167-223

[7] Fuchs HE(2008)Mechanisms of chemoresistance to alkylating agents in malignant glioma Clin Cancer Res 14 2900-2908

[8] Waite KA(2020)Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis Neuro-oncol Adv 2 vdaa082-1015

[9] Jemal A(2001)Glutamate release promotes growth of malignant gliomas Nat Med 7 1010-4391

[10] Siegel RL(1999)Glioma cells release excitotoxic concentrations of glutamate Can Res 59 4383-295

[1] Miller KD(2021)Brain and other central nervous system tumor statistics, 2021 Cancer J Clin 71 381-406

[2] Ostrom QT(2019)CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016 Neuro Oncol 21 v1-v100

[3] Kruchko C(2021)The 2021 WHO classification of tumors of the central nervous system: a summary Neuro Oncol 23 1231-1251

[4] Patil N(2005)Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987-996

[5] Tihan T(2005)MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 997-1003

[6] Cioffi G(1995)Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase Prog Nucleic Acid Res Mol Biol 51 167-223

[7] Fuchs HE(2008)Mechanisms of chemoresistance to alkylating agents in malignant glioma Clin Cancer Res 14 2900-2908

[8] Waite KA(2020)Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis Neuro-oncol Adv 2 vdaa082-1015

[9] Jemal A(2001)Glutamate release promotes growth of malignant gliomas Nat Med 7 1010-4391

[10] Siegel RL(1999)Glioma cells release excitotoxic concentrations of glutamate Can Res 59 4383-295